1. Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib. (October 2016) Authors: Sorensen, Steffen Filskov; Demuth, Christina; Weber, Britta; Sorensen, Boe Sandahl; Meldgaard, Peter Journal: Lung cancer Issue: Volume 100(2016) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer—a follow-up study. (July 2019) Authors: Ørum, Marianne; Jensen, Kenneth; Gregersen, Merete; Meldgaard, Peter; Damsgaard, Else Marie Journal: European journal of cancer Issue: Volume 116(2019) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project. (May 2019) Authors: Kerr, Keith M.; Thunnissen, Erik; Dafni, Urania; Finn, Stephen P.; Bubendorf, Lukas; Soltermann, Alex; Verbeken, Eric; Biernat, Wojciech; Warth, Arne; Marchetti, Antonio; Speel, Ernst-Jan M.; Pokharel, Sarawati; Quinn, Anne Marie; Monkhorst, Kim; Navarro, Atilio; Madsen, Line Bille; Radonic, Teod... Journal: Lung cancer Issue: Volume 131(2019) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients. (May 2020) Authors: Boysen Fynboe Ebert, Eva; McCulloch, Tine; Holmskov Hansen, Karin; Linnet, Hanne; Sorensen, Boe; Meldgaard, Peter Journal: Lung cancer Issue: Volume 143(2020) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer. (March 2020) Authors: Ebert, Eva Boysen Fynboe; McCulloch, Tine; Hansen, Karin Holmskov; Linnet, Hanne; Sorensen, Boe; Meldgaard, Peter Journal: Lung cancer Issue: Volume 141(2020) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study. (3rd April 2022) Authors: Mouritzen, Mette T.; Junker, Karen F.; Carus, Andreas; Ladekarl, Morten; Meldgaard, Peter; Nielsen, Anders W. M.; Livbjerg, Anna; Larsen, Jacob W.; Skuladottir, Halla; Kristiansen, Charlotte; Wedervang, Kim; Schytte, Tine; Hansen, Karin H.; Østby, Anne-Cathrine; Frank, Malene S.; Lauritsen, Jakob... Journal: Acta oncologica Issue: Volume 61:Number 4(2022) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TDP1 and TOP1 as targets in anticancer treatment of NSCLC: Activity and protein level in normal and tumor tissue from 150 NSCLC patients correlated to clinical data. (February 2022) Authors: Jakobsen, Ann-Katrine; Yuusufi, Sakineh; Madsen, Line Bille; Meldgaard, Peter; Knudsen, Birgitta R.; Stougaard, Magnus Journal: Lung cancer Issue: Volume 164(2022) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients. (September 2019) Authors: Hojbjerg, Johanne Andersen; Ebert, Eva Boysen Fynboe; Clement, Michelle Simone; Winther-Larsen, Anne; Meldgaard, Peter; Sorensen, Boe Journal: Lung cancer Issue: Volume 135(2019) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ultra-micro samples can be used for mRNA quantification of lung cancer biomarkers. (2nd April 2016) Authors: Sandfeld-Paulsen, Birgitte; Demuth, Christina; Folkersen, Birgitte H.; Rasmussen, Torben R.; Madsen, Line B.; Sorensen, Boe S.; Meldgaard, Peter Journal: Scandinavian journal of clinical & laboratory investigation Issue: Volume 76:Number 3(2016) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus. Issue 2 (February 2015) Authors: Cappuzzo, Federico; Moro-Sibilot, Denis; Gautschi, Oliver; Boleti, Ekaterini; Felip, Enriqueta; Groen, Harry J.M.; Germonpré, Paul; Meldgaard, Peter; Arriola, Edurne; Steele, Nicola; Fox, Jesme; Schnell, Patrick; Engelsberg, Arne; Wolf, Jürgen Journal: Lung cancer Issue: Volume 87:Issue 2(2015:Feb.) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗